June 18, 2024
The CAR T Cell Therapy Market is driven by increasing prevalence of cancer
The CAR T Cell Therapy market involves a treatment where a patient’s own T cells are engineered to express chimeric antigen receptors (CARs) to identify and attack cancer cells. CAR T-cell therapy harnesses the power of a patient’s immune system to recognize cancerous cells and eliminates them. This type of targeted immunotherapy is proving revolutionary…
naufancmi